Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cerulean Pharma Inc

+ Add to Watchlist

CERU:US

6.0800 USD 0.0100 0.16%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Cerulean Pharma Inc (CERU)

Open: 6.1700 Day's Range: 5.9500 - 6.7000 Volume: 594,853
Previous Close: 6.0700 52wk Range: 3.3500 - 10.8700 1-Yr Rtn: +6.48%

Stock Chart for CERU

No chart data available.
  • CERU:US 6.0800
  • 1D
  • 1M
  • 1Y
6.0700
Interactive CERU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERU

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4040
Est. EPS (USD) (12/2015) -1.6820
Est. PEG Ratio -
Market Cap (M USD) 165.89
Shares Outstanding (M) 27.28
30 Day Average Volume 225,348
Price/Book (mrq) 3.0948
Price/Sale (ttm) 3,110.6967
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CERU

Cerulean Pharma, Inc. designs and develops pharmaceutical products. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma operates in the United States.

Paul A FriedmanChairmanChristopher Damien T Guiffre "Chris"President/CEO
Edward G GarmeySenior VP/Chief Medical OfcrKaren L RobertsSenior VP:Finance & Admin
More Company Profile & Key Executives for CERU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil